[Toxoplasmosis in the heart transplant patient].
Toxoplasmosis is a well-known problem under immunosuppressive conditions in cardiac transplant patients. In our series 12% of the patients (8 of 65) had clinical and/or serological signs of active toxoplasmosis. Due to its serious prognosis once the clinical process has started we favor a generous diagnostic interpretation of the serological results and a broad indication to drug therapy.
Waser
M
M
Kardiologie und Herzgefasschirurgie, Universitätsspital Zürich.
Leonardi
L
L
Mohacsi
P
P
Laske
A
A
Turina
M
M
Gallino
A
A
D000818:Animals; D002311:Cardiomyopathy, Dilated / Q000601:surgery*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007074:Immunoglobulin G / Q000032:analysis; D009894:Opportunistic Infections / Q000276:immunology*; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology*
D007074:Immunoglobulin G
Die Toxoplasmose beim herztransplantierten Patienten.